UK MDs oppose selling statins without prescription
Leading physicians are condemning the UK's decision to allow patients to buy a cholesterol-lowering statin drug without prescriptions as a colossal "experiment."
In May, the UK declassified Simvastatin (Zocor), a statin, as an over-the-counter pharmaceutical, following advice from its Committee on Safety of Medicines. The drug will be available without prescription in a 10-mg dose -half the usual prescribed dosage -beginning this summer.
Health Secretary John Reid says statins save lives, and this will extend access to a successful drug.
But some physicians and consumer groups say the dosage has no proven efficacy and the drug may pose dangers to some.
Dr. Ike Iheanacho, deputy editor of the Drug and Therapeutics Bulletin, says there's no clinical evidence the drug is effective at 10 mg and the over-thecounter strategy has never been tested. "The whole thing is an experiment … with all the risks and limitations of experiments."
The British Medical Association (BMA) says the 10-mg dose may not be high enough to help people who really need it, and all statins carry the risk of side effects.
The move also means patients, not the government, will have to pay for the drug. "If a drug treatment is worth taking it should be provided equitably," says the BMA's Dr. John Chisholm.
The British Heart Foundation and the Royal Pharmaceutical Society of Great Britain support the reclassification.
The reclassification means the manufacturer can target a whole new market by advertising directly to consumers, says Iheanacho. "You can argue that it doesn't matter if it benefits industry as long as patients do well -but where is the evidence that patients will do well? Yet it is obvious that industry will do very well."
Johnson Rondeau denied that the Manitoba government is philosophically opposed to contracting with Jane's Clinic. He said more than a dozen different organizations, including Jane's Clinic, are negotiating with the Winnipeg Regional Health Authority to revamp women's health services.
Rondeau said his government is studying a plan to establish a $1-million "super clinic" for women, which would include abortion services. No timing has been announced. "Jane's clinic isn't necessarily going to be part of the solution, no," Rondeau said.
When the NDP government came into power in 1999, Morgentaler offered to donate his clinic to the province if the government paid for all abortions. However, negotiations between the province and Morgentaler broke down in late 2002, with each side accusing the other of bad faith.
Morgantaler sold the business in the "hope that by … removing myself entirely from the picture, the government will see its way clear to do what is right: fully fund procedures at the new Jane's Clinic."
The clinic has been an option for Manitoba women who can't get a government-funded abortion before their 16th week of pregnancy. In 2003, several women complained they were forced to visit the Morgentaler clinic and pay the fee because of waiting lists that would have taken them beyond 16 weeks. -Dan Lett, Winnipeg DOI:10.1503/cmaj.1040933 Morgantaler sold the clinic in the hope of obtaining government funding.
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